
<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>General Pharmacology - Pharmacology Study Guide</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="styles/main.css">
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>üìñ</span>
                        <span>Topic 01</span>
                    </div>
                    <h1 class="document-title">General Principles of Pharmacology</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Foundations, Pharmacokinetics & Pharmacodynamics</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>45 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- Section 1: Introduction -->
                    <section class="content-section" id="introduction">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üí°</span>
                                Introduction & Terminology
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Pharmacology is the study of the effects of chemical substances on the function of living systems. It encompasses the preparation, use, and effects of drugs.</p>
                            
                            <h3>Key Definitions</h3>
                            <dl class="enhanced-list">
                                <dt class="term-definition" data-definition="Any substance used in diagnosis, cure, treatment, or prevention of disease.">Drug</dt>
                                <dd>Any substance used in diagnosis, cure, treatment, and prevention of disease/condition or any substance that brings a change in biological functions through its chemical actions.</dd>
                                
                                <dt class="term-definition" data-definition="Study of how the body handles a drug (ADME).">Pharmacokinetics</dt>
                                <dd>The study of how the body acts on the drug. It involves <strong>A</strong>bsorption, <strong>D</strong>istribution, <strong>M</strong>etabolism (biotransformation), and <strong>E</strong>xcretion.</dd>
                                
                                <dt class="term-definition" data-definition="Study of how the drug acts on the body.">Pharmacodynamics</dt>
                                <dd>The study of how the drug acts on the body, including mechanism of action and dose-response relationships.</dd>
                                
                                <dt class="term-definition" data-definition="Study of drugs from natural sources.">Pharmacognosy</dt>
                                <dd>The study of drugs derived from natural sources such as plants, animals, and minerals.</dd>
                                
                                <dt class="term-definition" data-definition="Study of adverse effects of chemicals.">Toxicology</dt>
                                <dd>The branch dealing with undesirable effects of chemicals on living systems.</dd>
                            </dl>

                            <h3>Drug Nomenclature</h3>
                            <p>Drugs are typically identified by three names:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <div class="list-marker"></div>
                                    <div class="list-content"><strong>Chemical Name:</strong> Describes the molecular structure (e.g., <em>N-acetyl-para-aminophenol</em>).</div>
                                </li>
                                <li class="list-item">
                                    <div class="list-marker"></div>
                                    <div class="list-content"><strong>Generic Name:</strong> The official, approved non-proprietary name (e.g., <em>Paracetamol</em>, <em>Acetaminophen</em>). This is the preferred name for medical use.</div>
                                </li>
                                <li class="list-item">
                                    <div class="list-marker"></div>
                                    <div class="list-content"><strong>Trade/Brand Name:</strong> The proprietary name given by the manufacturer (e.g., <em>Panadol</em>, <em>Tylenol</em>).</div>
                                </li>
                            </ol>
                        </div>
                    </section>

                    <!-- Section 2: Drug Development -->
                    <section class="content-section" id="drug-development">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üî¨</span>
                                Drug Development
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Before a drug is approved for public use, it undergoes rigorous testing to ensure safety and efficacy.</p>

                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Phase</th>
                                                <th>Focus</th>
                                                <th>Subjects</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td><strong>Pre-clinical</strong></td>
                                                <td>Pharmacodynamics, pharmacokinetics, and toxicity (mutagenicity, carcinogenicity).</td>
                                                <td>Laboratory animals</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Phase I</strong></td>
                                                <td>Safety, dosage, and pharmacokinetics.</td>
                                                <td>Healthy human volunteers (20-50)</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Phase II</strong></td>
                                                <td>Therapeutic efficacy and dosing requirements.</td>
                                                <td>Patients with the disease (100-200)</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Phase III</strong></td>
                                                <td>Confirmation of efficacy and monitoring of adverse effects in a large population.</td>
                                                <td>Large patient groups (300-3000)</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Phase IV</strong></td>
                                                <td>Post-marketing surveillance/continuous evaluation of long-term safety.</td>
                                                <td>General population</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>
                            
                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ÑπÔ∏è</span>
                                    <h4 class="callout-title">Orphan Drugs</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Drugs discovered for rare diseases that may not be financially viable for companies to develop without incentives.</p>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Section 3: Drug Administration -->
                    <section class="content-section" id="administration">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíâ</span>
                                Drug Administration
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Principles of Administration</h3>
                            <p>To ensure patient safety, the "Rights" of medication administration must be followed:</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><div class="list-marker"></div><div class="list-content"><strong>Right Patient:</strong> Verify ID bracelet or call out name.</div></li>
                                <li class="list-item"><div class="list-marker"></div><div class="list-content"><strong>Right Drug:</strong> Check label three times (before removal, before preparation, before replacement).</div></li>
                                <li class="list-item"><div class="list-marker"></div><div class="list-content"><strong>Right Dose:</strong> Calculate accurately; avoid splitting non-scored tablets.</div></li>
                                <li class="list-item"><div class="list-marker"></div><div class="list-content"><strong>Right Route:</strong> Verify the prescribed route matches the formulation.</div></li>
                                <li class="list-item"><div class="list-marker"></div><div class="list-content"><strong>Right Time:</strong> Administer at the correct intervals relative to food/sleep.</div></li>
                            </ul>

                            <h3>Common Routes</h3>
                            <div class="collapsible-section">
                                <details>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        <strong>Enteral (Oral)</strong>
                                    </summary>
                                    <div class="collapsible-content">
                                        <p><strong>Pros:</strong> Convenient, safe, painless, economical, huge absorption surface area.</p>
                                        <p><strong>Cons:</strong> Variable absorption, first-pass metabolism, gastric irritation, requires patient compliance, slow onset.</p>
                                    </div>
                                </details>
                                <details>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        <strong>Parenteral (IV, IM, SC)</strong>
                                    </summary>
                                    <div class="collapsible-content">
                                        <p><strong>Intravenous (IV):</strong> 100% bioavailability, rapid onset, precise control, allows large volumes. <em>Risks:</em> Fluid overload, infection, embolism, immediate toxicity.</p>
                                        <p><strong>Intramuscular (IM):</strong> Suitable for depot preparations, easier than IV. <em>Risks:</em> Painful, potential nerve damage, abscess formation.</p>
                                    </div>
                                </details>
                                <details>
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ñ∂</span>
                                        <strong>Topical & Inhalation</strong>
                                    </summary>
                                    <div class="collapsible-content">
                                        <p><strong>Topical:</strong> High local concentration, minimal systemic effects. Includes skin, eyes, ears, vagina.</p>
                                        <p><strong>Inhalation:</strong> Rapid absorption due to large surface area of lungs, avoids first-pass effect. Used for local (asthma) or systemic (anesthesia) effects.</p>
                                    </div>
                                </details>
                            </div>
                        </div>
                    </section>

                    <!-- Section 4: Pharmacokinetics -->
                    <section class="content-section" id="pharmacokinetics">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üîÑ</span>
                                Pharmacokinetics (ADME)
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Pharmacokinetics describes "what the body does to the drug." It determines the onset, duration, and intensity of a drug's effect.</p>

                            <h3>1. Absorption</h3>
                            <p>Movement of drug from site of administration into the bloodstream. Factors affecting absorption include:</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><div class="list-marker"></div><div class="list-content"><strong>Lipid Solubility:</strong> Non-ionized, lipid-soluble drugs cross membranes easily.</div></li>
                                <li class="list-item"><div class="list-marker"></div><div class="list-content"><strong>Route of Administration:</strong> IV bypasses absorption entirely.</div></li>
                                <li class="list-item"><div class="list-marker"></div><div class="list-content"><strong>Blood Flow:</strong> Higher flow (e.g., intestine vs. stomach) favors absorption.</div></li>
                            </ul>
                            
                            <div class="callout callout--tip">
                                <div class="callout-header">
                                    <span class="callout-icon">üí°</span>
                                    <h4 class="callout-title">Bioavailability</h4>
                                </div>
                                <div class="callout-content">
                                    <p>The fraction of the administered dose that reaches the systemic circulation unchanged. IV administration = 100% bioavailability. Oral drugs often undergo <strong>First-Pass Metabolism</strong> in the liver before reaching circulation, reducing bioavailability.</p>
                                </div>
                            </div>

                            <h3>2. Distribution</h3>
                            <p>Transport of drug via blood to tissues. Dependent on:</p>
                            <ul>
                                <li><strong>Blood Flow:</strong> Well-perfused organs (heart, liver, kidneys, brain) receive drugs first.</li>
                                <li><strong>Protein Binding:</strong> Drugs bound to plasma proteins (like albumin) are inactive and trapped in the blood; only "free" drug is active and can distribute.</li>
                                <li><strong>Barriers:</strong> Blood-Brain Barrier (BBB) and Placental Barrier restrict passage of certain drugs (polar/ionized).</li>
                            </ul>

                            <h3>3. Metabolism (Biotransformation)</h3>
                            <p>The chemical alteration of the drug, primarily in the liver, to make it more water-soluble (hydrophilic) for excretion.</p>
                            
                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Phase</th>
                                                <th>Process</th>
                                                <th>Key Enzymes/Agents</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td><strong>Phase I</strong></td>
                                                <td>Functionalization (Oxidation, Reduction, Hydrolysis). Introduces/exposes functional groups.</td>
                                                <td>Cytochrome P450 (CYP) enzymes</td>
                                            </tr>
                                            <tr>
                                                <td><strong>Phase II</strong></td>
                                                <td>Conjugation. Adds large water-soluble groups to the molecule.</td>
                                                <td>Glucuronic acid, sulfate, glutathione, amino acids</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>
                            
                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Enzyme Induction & Inhibition</h4>
                                </div>
                                <div class="callout-content">
                                    <p><strong>Inducers (e.g., Barbiturates):</strong> Increase enzyme activity, speeding up metabolism of other drugs (reducing their effect).</p>
                                    <p><strong>Inhibitors (e.g., Cimetidine):</strong> Decrease enzyme activity, slowing metabolism of other drugs (increasing toxicity risk).</p>
                                </div>
                            </div>

                            <h3>4. Excretion</h3>
                            <p>Elimination of drugs/metabolites from the body.</p>
                            <ul>
                                <li><strong>Renal (Kidney):</strong> Primary route. Involves glomerular filtration and active tubular secretion. Lipophilic drugs may be reabsorbed; hydrophilic ones are excreted.</li>
                                <li><strong>Biliary/Fecal:</strong> Excretion via bile into intestines.</li>
                                <li><strong>Other routes:</strong> Lungs (volatile agents), breast milk, sweat, saliva.</li>
                            </ul>
                        </div>
                    </section>

                    <!-- Section 5: Pharmacodynamics -->
                    <section class="content-section" id="pharmacodynamics">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ö°</span>
                                Pharmacodynamics
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Pharmacodynamics describes "what the drug does to the body." It studies biochemical and physiological effects and mechanisms of action.</p>

                            <h3>Mechanism of Action</h3>
                            <p>Drugs typically interact with <strong>receptors</strong> (regulatory proteins) to produce an effect. Other targets include enzymes, ion channels, and transport proteins.</p>

                            <div class="key-points-section">
                                <div class="key-points-wrapper">
                                    <div class="key-points-header">
                                        <span class="key-points-icon">üîë</span>
                                        <h3 class="key-points-title">Receptor Concepts</h3>
                                    </div>
                                    <ul class="key-points-list">
                                        <li class="key-point-item">
                                            <span class="point-marker">‚óè</span>
                                            <div>
                                                <strong>Agonist:</strong> Binds to a receptor and activates it to produce a response (has affinity + intrinsic activity).
                                            </div>
                                        </li>
                                        <li class="key-point-item">
                                            <span class="point-marker">‚óè</span>
                                            <div>
                                                <strong>Antagonist:</strong> Binds to a receptor but prevents activation; blocks agonists (has affinity + zero intrinsic activity).
                                            </div>
                                        </li>
                                        <li class="key-point-item">
                                            <span class="point-marker">‚óè</span>
                                            <div>
                                                <strong>Partial Agonist:</strong> Binds to receptor but produces a sub-maximal response.
                                            </div>
                                        </li>
                                        <li class="key-point-item">
                                            <span class="point-marker">‚óè</span>
                                            <div>
                                                <strong>Affinity:</strong> The strength of attraction between a drug and its receptor.
                                            </div>
                                        </li>
                                        <li class="key-point-item">
                                            <span class="point-marker">‚óè</span>
                                            <div>
                                                <strong>Efficacy:</strong> The maximum response a drug can produce (intrinsic activity).
                                            </div>
                                        </li>
                                        <li class="key-point-item">
                                            <span class="point-marker">‚óè</span>
                                            <div>
                                                <strong>Potency:</strong> The dose required to produce a specific effect (lower dose = higher potency).
                                            </div>
                                        </li>
                                    </ul>
                                </div>
                            </div>

                            <h3>Therapeutic Index (TI)</h3>
                            <p>A measure of drug safety. It is the ratio of the toxic dose to the effective dose.</p>
                            <ul>
                                <li><strong>Wide TI:</strong> Safer drug (e.g., Penicillin). Large gap between effective and toxic dose.</li>
                                <li><strong>Narrow TI:</strong> Dangerous drug (e.g., Digoxin, Warfarin). Small gap; requires careful monitoring.</li>
                            </ul>
                            
                            <h3>Drug Interactions</h3>
                            <ul>
                                <li><strong>Synergism:</strong> Combined effect is greater than sum of individual effects (1+1 > 2).</li>
                                <li><strong>Additive:</strong> Combined effect equals sum of individual effects (1+1 = 2).</li>
                                <li><strong>Antagonism:</strong> One drug opposes the action of another.</li>
                            </ul>
                        </div>
                    </section>
                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="index.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Table of Contents</div>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>01</span>
                                <span class="progress-separator">/</span>
                                <span>05</span>
                            </div>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 20%;"></div>
                            </div>
                            <div class="progress-label">Topic Progress</div>
                        </div>
                        
                        <a href="topic-02-antimicrobial-chemotherapy.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Antimicrobial Agents</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <script src="js/theme.js"></script>
    <script>
        // Reading progress indicator
        const progressBar = document.getElementById('reading-progress');
        
        function updateReadingProgress() {
            const scrollTop = window.pageYOffset || document.documentElement.scrollTop;
            const scrollHeight = document.documentElement.scrollHeight - document.documentElement.clientHeight;
            const scrollPercent = (scrollTop / scrollHeight) * 100;
            
            progressBar.style.width = Math.min(scrollPercent, 100) + '%';
        }
        
        window.addEventListener('scroll', updateReadingProgress);
        
        // Active navigation highlighting
        function updateActiveNavigation() {
            const sections = document.querySelectorAll('.content-section');
            const navLinks = document.querySelectorAll('.floating-toc-list a');
            
            let currentSection = '';
            
            sections.forEach(section => {
                const sectionTop = section.offsetTop - 150;
                const sectionHeight = section.offsetHeight;
                
                if (window.pageYOffset >= sectionTop && window.pageYOffset < sectionTop + sectionHeight) {
                    currentSection = section.getAttribute('id');
                }
            });
            
            navLinks.forEach(link => {
                link.classList.remove('active');
                if (link.getAttribute('href') === '#' + currentSection) {
                    link.classList.add('active');
                }
            });
        }
        
        window.addEventListener('scroll', updateActiveNavigation);
    </script>
</body>
</html>